deaths (OS)progression or deaths (PFS)RFS/DFS

mNSCLC - L1 - PDL1 positive metastatic/advanced NSCLC (mNSCLC) - 1st line (L1) mNSCLC - L1 - PDL1 positive

versus Standard of Care (SoC)
durvalumab alone vs. Standard of Care (SoC) 1 -1275 [-2235; -316] /10000
108/163 vs. 128/162
-411 [-1431; 610] /10000
106/163 vs. 112/162
-